#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary hypophosphataemic rickets Cutaneous T-cell lymphoma refractory Phenylketonuria Oesophageal squamous cell carcinoma stage III Glioma Squamous cell carcinoma of the vulva T-cell lymphoma Liposarcoma Endometrial adenocarcinoma B precursor type acute leukaemia Myotonic dystrophy Atopic keratoconjunctivitis Solitary fibrous tumour Anal cancer recurrent Hepatoblastoma More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Diagnostics Short-bowel syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Trials in Disease MELAS syndrome Basal cell naevus syndrome Biotinidase deficiency – Basic Information Aicardi-Goutieres syndrome – Trials in Disease Mantle cell lymphoma stage IV – Life with Disease Glycogen storage disease type II – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cldn6 Rna-Lpx Irinotecan Hydrochloride Lumasiran Aciclovir Migalastat Regn7257 Aspartic Acid [18F]DED Brigatinib Teplizumab Mercaptopurine Ro7247669 Roflumilast Betamethasone Valerate Dexrazoxane Hydrochloride Bictegravir Mva-209-Fsp-B3 Vsf1.01 Pemetrexed Avalotcagene Ontaparvovec More therapies…

    Learn about Your Condition

    Endometrial cancer stage III Stem cell transplant Ocular hypertension Juvenile idiopathic arthritis Pneumonia chlamydial Burkitt's lymphoma Colorectal cancer metastatic Erythema migrans Andersen-Tawil syndrome BRAF gene mutation Prolymphocytic leukaemia Anal cancer recurrent Body mass index increased Macular degeneration Peripheral artery thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of tamoxifen loading dose and Ki67 response in breast cancer patients before surgery (ENDO-67)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tamoxifen
    The Netherlands

  • Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

    Not yet recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Lactobacillus Rhamnosus, Strain Lcr35, Live
    • Ozanimod
    • Ofatumumab
    Poland

  • Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    France

  • Study comparing amoxicillin/clavulanic acid treatment versus surgery for children with uncomplicated appendicitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Cefoxitin
    • Clavulanic Acid
    • Amoxicillin
    France

  • Study of Pozelimab and Cemdisiran in Adults with Paroxysmal Nocturnal Hemoglobinuria Not Responding Well to Current C5 Inhibitor Treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Italy Poland Spain

  • Study of Aspirin and Folic Acid Treatment for Patients with Sudden Sensorineural Hearing Loss

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Folic Acid
    • Acetylsalicylic Acid
    France
Previous Page
1 … 764 765 766 767 768 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!